Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

In the present protocol, a mouse heart transplantation model is used for investigating the mechanism of cardiac allograft rejection. In this heterotopic heart transplantation model, operation efficiency is improved, and the survival of cardiac grafts is ensured by a cervical end-to-end anastomosis of heart implantation using a modified Cuff technique.

Abstract

Cardiac allograft rejection limits the long-term survival of patients after heart transplantation. A mouse heart transplantation model is ideal for investigating the mechanism of cardiac allograft rejection in preclinical studies because of their high homology with human genes. This understanding would help develop unique approaches to improving patients' long-term survival treated with cardiac allografts. In a mouse model, abdominal donor heart implantation is commonly performed with an end-to-end anastomosis to the recipient's aorta and inferior vena cava using stitches. In this model, the donor's heart is implanted by end-to-end anastomosis to the recipient's carotid artery and jugular vein by the modified-Cuff technique. The transplantation surgery is performed without stitching and thus may increase the survival of the recipient since there is no interference with the blood supply and venous reflux of the lower body. This mouse model would help investigate the mechanisms underlying the immunological and pathological (acute/chronic) rejection of cardiac allografts.

Introduction

Heart transplantation has become the standard treatment for terminal heart failure. More than 5,500 heart transplantations per year are performed in the organizations registered under the International Society for Heart and Lung Transplantation. Among the allogeneic heart transplant recipients, the 1-year rejection rate is still >10%, while the 3-year rejection rate increased to 36%1,2. However, effective prophylactic treatments for patients with cardiac allograft rejection are lacking. Therefore, animal model studies are warranted that elucidate the physiological mechanisms underlying the immunological an....

Protocol

All Animal experiments were performed in compliance with the Guide for the Care and Use of Laboratory Animals, Eight Edition, National Research Council (US) 2011. Procedures involving animal subjects have been approved by the Animal Care and Use Committee of the Chongqing University Cancer Hospital, Chongqing, China. Male BALB/c and C57BL/6 mice weighing 20-30 g, obtained from commercial sources (see Table of Materials), were used for allogeneic heart transplantation study. The C57BL/6 mice were use.......

Representative Results

In this mouse cervical heterotopic heart transplantation model, the survival rate of recipient mice was approximately 95.2% (20 out of 21 mice survived). The primary cause of death was postoperative bleeding. The fast heartbeat with a regular rhythm serves as an indicator of the survival of the implanted donor heart.

C57BL/6 and BALB/c mice were MHC (H-2b) and MHC (H-2d) types in this model, respectively7,8. These two strains differ by.......

Discussion

The mouse heart transplantation model contributes to the investigation of rejection mechanisms after heart transplantation, contributing to the development of unique approaches to improve the long-term survival of cardiac allograft recipients. However, heart transplantation in mice is a complex and challenging task, requiring a high level of microsurgery techniques, especially in vascular anastomosis11,12,13. The mouse abdominal.......

Acknowledgements

This work was supported by the National Natural Science Foundation of China (81870304) to Jun Li.

....

Materials

NameCompanyCatalog NumberComments
 5-0 Polyamide Monofilament sutureB.Braun Medical Inc.C3090954
 8-0 Polyamide Monofilament sutureB.Braun Medical Inc.C2090880
10-0 Polyamide Monofilament sutureB.Braun Medical Inc.G0090781
22 G polyurethane cuffB.Braun Medical Inc.4251628-02
26 G polyurethane cuffSuzhou Linhua Medical Instrument Co., LTDREF383713
Anesthesia induction chamberRWD Life Science Co., LTDV100
Atraumatic microvascular clampBeyotimeFS500
BALB/c and C57BL/6 mice (20–30 g)Centre of Experimental Animals (Army Medical University, Chongqing, China)
BuprenorphineUS Biological life Sciences352004
ElectrocoagulatorGuangzhou Runman Medical Instrument Co., LTDZJ1099
GauzeHenan piaoan group Co., LTD10210402
Heating padGuangzhou Dewei Biological Technology Co., LTDDK0032
HeparinNorth China Pharmaceutical Co., LTD2101131-2
HTK solutionShenzhen Changyi Pharmaceutical Co., LTDYZB/Min8263-2013
Injection syringe (10 mL)Shandong weigao group medical polymer Co., LTD20211001
IsofluraneRWD Life Science Co., LTD21070201
Physiological salineSouthwest pharmaceutical Co., LTDH50021610
Scalp needleHongyu Medical Group20183150210
ShaverBeyotimeFS600
Small animal anesthesia machineRWD Life Science Co., LTDR500
Surgical operation microscopeTiannuoxiang Scientific Instrument Co. , Ltd, Beijing, ChinaSZX-6745
SwabYubei Medical Materials Co., LTD21080274

References

Explore More Articles

Mouse Heart TransplantationCervical HeterotopicCuff TechniqueVessel AnastomosisCardiac AllograftImmunologic RejectionSurgical ProcedureRecipient MouseExternal Jugular VeinCommon Carotid ArteryMicrovascular ClampPolyurethane CuffSutureHeparin Saline

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved